Triamcinolone acetonide

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: Triamcinolone acetonide
Generic name: TRIAMCINOLONE ACETONIDE
Manufacturer: Redpharm Drug
Product type: HUMAN PRESCRIPTION DRUG
SPL set ID: 5a79639b-eb66-e726-e063-6394a90aeb01
SPL ID: 5a7962f5-643f-e6df-e063-6394a90ab86d
Version: 1
Effective date: 2026-09-02
Source export date: 2026-10-27
Source partition: 8
Source file: https://download.open.fda.gov/drug/label/drug-label-0008-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-10-27/2eee27992d1f29d82f827fd5be42f1314ed39ce4c497af5d81435ac6656a0957/drug-label-0008-of-0014.json.zip
Source manifest SHA-256: 6be3667a3beefe6c0ead4c723ea963050533a2bc725a8044d58b07d18b258c55
Import run: 20261027T193451Z
Imported at: 2026-10-27 20:25:36

Harmonized routes table
Harmonized routes
TOPICAL

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 12 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
application applno	ANDA	209828	derived:openfda.application_number
application number		ANDA209828	openfda.application_number
brand name		Triamcinolone acetonide	openfda.brand_name
generic name		TRIAMCINOLONE ACETONIDE	openfda.generic_name
manufacturer name		Redpharm Drug	openfda.manufacturer_name
ndc	package	67296-2327-1	openfda.package_ndc
ndc	product	67296-2327	openfda.product_ndc
ndc11	package	67296232701	derived:openfda.package_ndc
rxcui		1085636	openfda.rxcui
spl id		5a7962f5-643f-e6df-e063-6394a90ab86d	id
spl set id		5a79639b-eb66-e726-e063-6394a90aeb01	set_id
unii		F446C597KA	openfda.unii

Adverse reactions cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Adverse reactions sections page 1 of 1 · 1 matching rows.

adverse reactions

ADVERSE REACTIONS The following local adverse reactions are reported infrequently with topical corticosteroids, but may occur more frequently with the use of occlusive dressings (reactions are listed in an approximate decreasing order of occurrence): burning, itching, irritation, dryness, folliculitis, hypertrichosis, acneiform eruptions, hypopigmentation, perioral dermatitis, allergic contact dermatitis, maceration of the skin, secondary infection, skin atrophy, striae, and miliaria.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.